Two Sigma Investments »

Nuvectis Pharma shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $83k 13k 6.33
2023-12-31 $190k 23k 8.34

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Carnival Corp Unit 99/99/9999 Put Option (CCL)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
Carvana Cl A (CVNA)
Snowflake Cl A (SNOW)
Bristol Myers Squibb (BMY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Uber Technologies Put Option (UBER)

View all positions for Two Sigma Investments

Top funds holding Nuvectis Pharma

Vanguard Group
Baldwin Brothers
BlackRock
Geode Capital Management
Goldman Sachs Group
Iridian Asset Management
GSA Capital Partners
BlackRock
Paul Kendrigan
Marshall Wace
Susquehanna International
Renaissance Technologies
State Street Corporation
Northern Trust
Two Sigma Investments

View all funds holding Nuvectis Pharma